Dose-adjusted EPOCH with Rituximab (DA-EPOCH-R)
Treatment used for 1 condition
Total Trials
3
Total Participants
3K
Avg Effectiveness
85%
Avg Safety Score
25%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.